Nello Mainolfi - 10 Jan 2025 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Chief Executive Officer, Director
Signature: /s/ Bruce Jacobs, as Attorney-in-Fact
Issuer symbol: KYMR
Transactions as of: 10 Jan 2025
Net transactions value: +$20,800
Form type: 4
Filing time: 13 Jan 2025, 07:00:04 UTC
Previous filing: 01 Jul 2024
Next filing: 03 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYMR	Common Stock	Options Exercise	$20,800	+10,000	+1.5%	$2.08	659,959	10 Jan 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	+10,000	+2.1%	$0.000000	495,559	10 Jan 2025	Common Stock	10,000	$2.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this stock option vested in forty-eight (48) equal monthly installments following the vesting commencement date of November 14, 2019, subject to the reporting person's continued employment through each vesting date.